[1]IMYANITOV EN,IYEVLEVA AG,LEVCHENKO EV.Molecular testing and targeted therapy for non-small cell lung cancer:Current status and perspectives[J].Crit Rev Oncol Hematol,2021,157:103194.
[2]SANKAR K,GADGEEL SM,QIN A.Molecular therapeutic targets in non-small cell lung cancer[J].Expert Rev Anticancer Ther,2020,20(8):647-661.
[3]KONG F,WANG Z,LIAO D,et al.Non-small cell lung cancer:Challenge and improvement of immune drug resistance[J].Front Oncol,2021,11:739191.
[4]JONNA S,SUBRAMANIAM DS.Molecular diagnostics and targeted therapies in non-small cell lung cancer(NSCLC):an update[J].Discov Med,2019,27(148):167-170.
[5]AHN YH,KO YH.Diagnostic and therapeutic implications of microRNAs in non-small cell lung cancer[J].Int J Mol Sci,2020,21(22):8782.
[6]ZHONG S,GOLPON H,ZARDO P,et al.miRNAs in lung cancer.A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer[J].Transl Res,2021,230:164-196.
[7]EBRAHIMI SO,REIISI S,SHAREEF S.miRNAs,oxidative stress,and cancer:A comprehensive and updated review[J].J Cell Physiol,2020,235(11):8812-8825.
[8]YU B,YOU W,CHEN G,et al.MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer[J].Cell Cycle,2019,18(20):2641-2650.
[9]FANG Z,YIN S,SUN R,et al.miR-140-5p suppresses the proliferation,migration and invasion of gastric cancer by regulating YES1[J].Mol Cancer,2017,16(1):139.
[10]TANG YH,HE GL,HUANG SZ,et al.The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma[J].Mol Oncol,2019,13(5):1296-1310.
[11]CASLINI C,HONG S,BAN YJ,et al.HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells[J].Oncogene,2019,38(39):6599-6614.
[12]ZHU T,BAO X,CHEN M,et al.Mechanisms and future of non-small cell lung cancer metastasis[J].Front Oncol,2020,10:585284.
[13]SUSTER DI,MINO-KENUDSON M.Molecular pathology of primary non-small cell lung cancer[J].Arch Med Res,2020,51(8):784-798.
[14]YANG P,XIONG J,ZUO L,et al.miR-140-5p regulates cell migration and invasion of non-small cell lung cancer cells through targeting VEGFA[J].Mol Med Rep,2018,18(3):2866-2872.
[15]ZHOU W,WANG X,YIN D,et al.Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism[J].Exp Ther Med,2019,18(2):1350-1356.
[16]LI Q,YAO Y,EADES G,et al.Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer[J].Oncogene,2014,33(20):2589-2600.
[17]GAO S,LIU H,HOU S,et al.MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer[J].Clin Transl Oncol,2018,20(6):703-712.
[18]CUTANO V,DI GIORGIO E,MINISINI M,et al.HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells[J].Mol Oncol,2019,13(8):1651-1668.
[19]YU X,WANG M,WU J,et al.ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway[J].J Exp Clin Cancer Res,2019,38(1):40.
[20]SANG Y,SUN L,WU Y,et al.Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis[J].Int J Oncol,2019,54(3):1112-1122.
[21]PEIXOTO P,BLOMME A,COSTANZA B,et al.HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN:new opportunities for selected targeted therapies[J].Oncogene,2016,35(34):4481-4494.
[22]YU Y,CAO F,YU X,et al.The expression of HDAC7 in cancerous gastric tissues is positively associated with distant metastasis and poor patient prognosis[J].Clin Transl Oncol,2017,19(8):1045-1054.
[23]LIM HJ,CROWE P,YANG JL.Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer[J].J Cancer Res Clin Oncol,2015,141(4):671-689.